ERGIC3 Antibody (N-term) Blocking Peptide

Produktübersicht

• Artikelname: ERGIC3 Antibody (N-term) Blocking Peptide
• Artikelnummer: ABT-BP9217A
• Hersteller Artikelnummer: BP9217a
• Alternativnummer: ABT-BP9217A-500UG
• Hersteller: Abcepta
• Kategorie: Proteine/Peptide
• Alternative Synonym: Endoplasmic reticulum-Golgi intermediate compartment protein 3, Serologically defined breast cancer antigen NY-BR-84, ERGIC3, C20orf47, ERV46, SDBCAG84

Produktbeschreibung

ERGIC3 is possible role in transport between endoplasmic reticulum and Golgi.

Produkteigenschaften

• NCBI: 51614
• UniProt: Q9Y282
• Formulierung: Peptides are lyophilized in a solid powder format. Peptides can be reconstituted in solution using the appropriate buffer as needed.
• Target-Kategorie: The synthetic peptide sequence used to generate the antibody AP9217a was selected from the N-term region of human ERGIC3. A 10 to 100 fold molar excess to antibody is recommended. Precise conditions should be optimized for a particular assay.